|
1
|
Fontaine V, Balducci C, Dinan L, Monteiro E, Boumedine T, Fournié M, Nguyen V, Guibout L, Clatot J, Latil M, Veillet S, Sahel JA, Lafont R, Dilda PJ, Camelo S. Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD). Int J Mol Sci 2023; 24:5296. [PMID: 36982372 PMCID: PMC10049354 DOI: 10.3390/ijms24065296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2023] [Revised: 02/16/2023] [Accepted: 03/06/2023] [Indexed: 03/12/2023] Open
Abstract
9'-cis-norbixin (norbixin/BIO201) protects RPE cells against phototoxicity induced by blue light and N-retinylidene-N-retinylethanolamine (A2E) in vitro and preserves visual functions in animal models of age-related macular degeneration (AMD) in vivo. The purpose of this study was to examine the mode of action and the in vitro and in vivo effects of BIO203, a novel norbixin amide conjugate. Compared to norbixin, BIO203 displays improved stability at all temperatures tested for up to 18 months. In vitro, BIO203 and norbixin share a similar mode of action involving the inhibition of PPARs, NF-κB, and AP-1 transactivations. The two compounds also reduce IL-6, IL-8, and VEGF expression induced by A2E. In vivo, ocular maximal concentration and BIO203 plasma exposure are increased compared to those of norbixin. Moreover, BIO203 administered systemically protects visual functions and retinal structure in albino rats subjected to blue-light illumination and in the retinal degeneration model of Abca4-/- Rdh8-/- double knock-out mice following 6 months of oral complementation. In conclusion, we report here that BIO203 and norbixin share similar modes of action and protective effects in vitro and in vivo. BIO203, with its improved pharmacokinetic and stability properties, could be developed for the treatment of retinal degenerative diseases such as AMD.
Collapse
Affiliation(s)
- Valérie Fontaine
- Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France; (V.F.)
| | - Christine Balducci
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France (S.C.)
| | - Laurence Dinan
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France (S.C.)
| | - Elodie Monteiro
- Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France; (V.F.)
| | - Thinhinane Boumedine
- Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France; (V.F.)
| | - Mylène Fournié
- Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France; (V.F.)
| | - Vincent Nguyen
- Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France; (V.F.)
| | - Louis Guibout
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France (S.C.)
| | - Justine Clatot
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France (S.C.)
| | - Mathilde Latil
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France (S.C.)
| | - Stanislas Veillet
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France (S.C.)
| | - José-Alain Sahel
- Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France; (V.F.)
- Fondation Ophtalmologique Rothschild, 29 rue Manin, 75019 Paris, France
- Department of Ophthalmology, School of Medicine, The University of Pittsburgh, Pittsburgh, PA 15213, USA
| | - René Lafont
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France (S.C.)
| | - Pierre J. Dilda
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France (S.C.)
| | - Serge Camelo
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France (S.C.)
| |
Collapse
|
|
2
|
Fontaine V, Camelo S, Christine B, Laurence D, Monteiro E, Boumedine T, Nguyen V, Fournié M, Clatot J, Latil M, Veillet S, Lafont R, Dilda P. In vitro and in vivo characterization of
BIO203
, a new amide norbixin conjugate with improved pharmacokinetic profile. Potential for oral treatment of age‐related retinal degeneration. Acta Ophthalmol 2022. [DOI: 10.1111/j.1755-3768.2022.0797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Affiliation(s)
- Valérie Fontaine
- INSERM, CNRS, Institut de la Vision Sorbonne Université Paris France
| | | | | | | | - Elodie Monteiro
- INSERM, CNRS, Institut de la Vision Sorbonne Université Paris France
| | | | - Vincent Nguyen
- INSERM, CNRS, Institut de la Vision Sorbonne Université Paris France
| | - Mylene Fournié
- INSERM, CNRS, Institut de la Vision Sorbonne Université Paris France
| | | | | | | | | | | |
Collapse
|
|
4
|
Allam R, Galal W, El-Damnhoury H, Mortada A, Guo R, Fang F, Xie JM, Zhang Q, Chan YS, Fung WH, Razali O, Azlan H, Lam KH, Chan CK, Yu CM, Wong FMF, Sit JWH, Wong EML, Lee V, Hemingway H, Harb R, Crake T, Lambiase P, Zhao QY, Yu SB, Huang H, Qin M, Cui HY, Huang T, Huang CX, Leung YW, Yue CS, Leung KF, Fung CYR, Mak YMW, Chow KS, Tang SK, Sperzel J, Tscheliessnigg K, Bucx JJJ, Silvestre J, Oza AL, Yu Mironov N, Golitsyn SP, Sokolov SF, Yuricheva YA, Maikov EB, Shlevkov NB, Mareev YV, Rosenstraukh LV, Chazov EI, Li BN, Qin J, Xiang K, Pang WM, Wang LS, Wu HS, Qin J, Wong TT, Yu CM, Heng PA, Clatot J, Ziyadeh-Isleem A, Coulombe A, Maugenre S, Dilanian G, Hatem S, Denjoy I, Neyroud N, Guicheney P, Plameras GB, Valentin MV, Ramirez M, Suga C, Hirahara T, Sugawara Y, Nakajima J, Wakaba H, Ako J, Momomura S, Ye Volkov D, Karpenko YI, Lopin DA, Chair SY, Lee JCK, Choi KC, Sit JWH, Wong EM, Chan CWH, So WKW, Cheng AHY, Hamid AK, Lainchbury JG, Troughton RW, Yandle TG, Frampton CM, Richards AM. P001 * Reversal of endothelial dysfunction after AF cardioversion. Eur Heart J Suppl 2012. [DOI: 10.1093/eurheartj/sur022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|